Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Kathy L. Ketchum"'
1
Initial Results of the Use of Prescription Order Change Forms to Achieve Dose Form Optimization (Consolidation and Tablet Splitting) of SSRI Antidepressants in a State Medicaid Program
Autor: David A. Pollack, Dean G. Haxby, Daniel M. Hartung, Kathy L. Ketchum, Ann M. Hamer
Publikováno v: Journal of Managed Care Pharmacy. 12:449-456
One method to reduce drug costs is to promote dose form optimization strategies that take advantage of the flat pricing of some drugs, i.e., the same or nearly the same price for a 100 mg tablet and a 50 mg tablet of the same drug. Dose form optimiza
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d01a750f0af21d0c357bcfd062f8b9bb
https://doi.org/10.18553/jmcp.2006.12.6.449
Zobrazit plný text záznamu
2
Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population
Autor: Daniel M. Hartung, Merwyn R. Greenlick, Dale F. Kraemer, Dean G. Haxby, Matthew J. Carlson, Kathy L. Ketchum
Publikováno v: Medical care. 46(6)
Copayments (copays) for prescription drugs are a common policy among state Medicaid programs. Research exploring the effects of copays on pharmacy and health care utilization in Medicaid patients is limited, especially among patients with chronic dis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3f7079eaa7970b2b4a72cf5c5fc11c3
https://pubmed.ncbi.nlm.nih.gov/18520310
Zobrazit plný text záznamu
3
Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
Autor: Steve Stoner, Daniel R. Touchette, Margaret E. McGuinness, Jennifer M. Edwards, Kathy L. Ketchum, David Shute
Publikováno v: Pharmacy Practice (Granada) v.6 n.1 2008
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice (Granada), Volume: 6, Issue: 1, Pages: 43-50, Published: MAR 2008
Pharmacy Practice
Scopus-Elsevier
Atrial fibrillation affects an estimated 5 million Americans and accounts for approximately 15% of all strokes. Few studies have successfully addressed patient screening, assessment, and introduction of appropriate antithrombotic therapy in patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e96832f27359384d23b56b328ef79b3
https://doi.org/10.4321/s1886-36552008000100007
Zobrazit plný text záznamu
4
Rates of adverse events of long-acting opioids in a state Medicaid program
Autor: Dean G. Haxby, Kathy L. Ketchum, Michele Koder, Roger Chou, Daniel M. Hartung, Luke Middleton
Publikováno v: The Annals of pharmacotherapy. 41(6)
BACKGROUND: Despite widespread use and emerging safety concerns, data on the comparative safety and effectiveness of long-acting opioid (LAO) analgesics are weak. OBJECTIVE: To compare rates of adverse events among patients newly prescribed an LAO. M
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cacf2c52784c105e743ad3d78cdf15e
https://pubmed.ncbi.nlm.nih.gov/17504834
Zobrazit plný text záznamu
5
Changes in Long-acting β-agonist Utilization After the FDA’s 2010 Drug Safety Communication
Autor: Daniel M. Hartung, Luke Middleton, Sheila Markwardt, Kaylee Williamson, Kathy L. Ketchum
Publikováno v: Clinical Therapeutics. 37:114-123.e1
Purpose In February 2010, the US Food and Drug Administration (FDA) issued new recommendations for the safe use of long-acting β-agonists (LABAs) in patients with asthma. The objective of this study was to determine the impact of the FDA’s 2010 sa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af3eb4f28cbead0c14af48e4dc4b224a
https://doi.org/10.1016/j.clinthera.2014.10.025
Zobrazit plný text záznamu
6
An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug Plan
Autor: Kathy L. Ketchum, Daniel M. Hartung, Dean G. Haxby
Publikováno v: Health affairs (Project Hope). 25(5)
This paper describes Oregon’s implementation of its publicly developed, evidence-based, Practitioner-Managed Prescription Drug Plan (PMPDP). Oregon’s PMPDP was initially self-enforced with a dispense as written (DAW) exception process, followed b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040dec656899ebb3c376a21facdb1cc8
https://pubmed.ncbi.nlm.nih.gov/16966742
Zobrazit plný text záznamu
7
Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population
Autor: Kathy L. Ketchum, Bruce Goldberg, Daniel R. Touchette, Daniel M. Hartung, Dean G. Haxby
Publikováno v: Clinical therapeutics. 26(9)
Prior authorization (PA) is a poorly studied but commonly employed policy used by health care payers to manage the rising costs of pharmacy benefits.The aim of this study was to evaluate the intended and unintended effects of a PA policy for celecoxi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ff2162c4810cb95c38485adc73e316
https://pubmed.ncbi.nlm.nih.gov/15531015
Zobrazit plný text záznamu
8
Gabapentin use in a managed medicaid population
Autor: Kathy L. Ketchum, Bentson H. McFarland, Ann M. Hamer, Dean G. Haxby
Publikováno v: Journal of managed care pharmacy : JMCP. 8(4)
OBJECTIVE: The use of gabapentin, an antiepileptic agent, in a primary care setting was evaluated to determine (a) the conditions being treated, (b) specialties of the prescribers, (c) dose ranges, and (d) the extent of documentation and follow-up. M
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a444bd3ab8f112ddb1d6e0f6b983b37
https://pubmed.ncbi.nlm.nih.gov/14613426
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje